LBA2 POD1UM-303/InterAACT 2: Phase III study of retifanlimab with carboplatin-paclitaxel (c-p) in patients (Pts) with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC) not previously treated with systemic chemotherapy (Chemo)

Sheela Rao, E. Samalin-Scalzi, Ludovic Evesque, Méher Ben Abdelghani, Federica Morano, A.C. Roy, Laëtitia Dahan, Stefano Tamberi, A.S. Dhadda, Mark Saunders, Nuno Casanova, Rosine Guimbaud, Astrid Lièvre, Joan Maurel, Marwan Fakih, Peipei Zhang, Jonathan S. Harrison, Michelle Jones, J-P. Spano, Pauline Rochefort